Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.
2.

Cholinesterase inhibitors for Alzheimer's disease.

Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. Review.

PMID:
16437532
3.

Donepezil for dementia due to Alzheimer's disease.

Birks J, Harvey RJ.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001190. Review.

PMID:
16437430
4.

Donepezil for dementia due to Alzheimer's disease.

Birks JS, Harvey R.

Cochrane Database Syst Rev. 2003;(3):CD001190. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD001190.

PMID:
12917900
5.

Donepezil for vascular cognitive impairment.

Malouf R, Birks J.

Cochrane Database Syst Rev. 2004;(1):CD004395. Review.

PMID:
14974068
6.

Donepezil for mild and moderate Alzheimer's disease.

Birks J S, Melzer D.

Cochrane Database Syst Rev. 2000;(2):CD001190. Review. Update in: Cochrane Database Syst Rev. 2000;(4):CD001190.

PMID:
10796620
8.

Ginkgo biloba for cognitive impairment and dementia.

Birks J, Grimley Evans J.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003120. doi: 10.1002/14651858.CD003120.pub3. Review.

PMID:
19160216
9.

Donepezil for mild and moderate Alzheimer's disease.

Birks JS, Melzer D, Beppu H.

Cochrane Database Syst Rev. 2000;(4):CD001190. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD001190.

PMID:
11034704
10.

Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials.

Gauthier S, Schlaefke S.

Clin Interv Aging. 2014 Nov 28;9:2065-77. doi: 10.2147/CIA.S72728. eCollection 2014. Review.

11.

Ginkgo biloba for cognitive impairment and dementia.

Birks J, Grimley EV, Van Dongen M.

Cochrane Database Syst Rev. 2002;(4):CD003120. Review. Update in: Cochrane Database Syst Rev. 2007;(2):CD003120.

PMID:
12519586
12.

Effects of Ginkgo biloba extract EGb 761 ® in dementia with neuropsychiatric features: review of recently completed randomised, controlled trials.

Ihl R.

Int J Psychiatry Clin Pract. 2013 Nov;17 Suppl 1:8-14. doi: 10.3109/13651501.2013.814796. Epub 2013 Aug 27. Review.

PMID:
23808613
13.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
14.

Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.

von Gunten A, Schlaefke S, Überla K.

World J Biol Psychiatry. 2016 Dec;17(8):622-633. Epub 2015 Jul 30. Review.

PMID:
26223956
15.

[Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].

Kasper S, Schubert H.

Fortschr Neurol Psychiatr. 2009 Sep;77(9):494-506. doi: 10.1055/s-0028-1109504. Epub 2009 Jul 20. Review. German.

PMID:
19621278
16.
17.

Review about Ginkgo biloba special extract EGb 761 (Ginkgo).

Gertz HJ, Kiefer M.

Curr Pharm Des. 2004;10(3):261-4. Review.

PMID:
14754386
18.

Gingko biloba extract EGb 761®: clinical data in dementia.

Ihl R.

Int Psychogeriatr. 2012 Aug;24 Suppl 1:S35-40. doi: 10.1017/S1041610212000543. Review.

PMID:
22784427
19.

[Value of Ginkgo biloba in treatment of Alzheimer dementia].

Loew D.

Wien Med Wochenschr. 2002;152(15-16):418-22. Review. German.

PMID:
12244890
20.

Evidence-based pharmacotherapy of Alzheimer's disease.

Evans JG, Wilcock G, Birks J.

Int J Neuropsychopharmacol. 2004 Sep;7(3):351-69. Epub 2004 Jul 1. Review.

PMID:
15228642

Supplemental Content

Support Center